3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
7
Ovarian Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Metastatic Solid Tumors
1
Mesothelioma
1
Lung Neoplasms
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Advanced Solid Tumors
1
Interventions
Granulocyte Colony-Stimulating Factor
3
Thiotepa
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
sodium thiosulfate
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
cixutumumab
1
X-Rays
1
Ursodeoxycholic Acid
1
Topotecan
1
Thalidomide
1
Specimen Handling
1
Sirolimus
1
Simvastatin
1
Radiation
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Leukapheresis
1
LY2940680
1
Immunologic Techniques
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Platinum
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled